Ventriculolumbar perfusion chemotherapy with methotrexate and cytosine arabinoside for meningeal carcinomatosis: A pilot study in 13 patients
Authors:
- 1 March 1996
- journal article
- clinical trial
- Published by Elsevier in Surgical Neurology
- Vol. 45 (3) , 256-263
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis.Journal of Clinical Oncology, 1987
- Combination intraventricular chemotherapy for meningeal neoplasia.Journal of Clinical Oncology, 1986
- Pharmacokinetics and biochemical effects of a fatal intrathecal methotrexate overdoseCancer, 1982
- Leukoencephalopathy and Elevated Levels of Myelin Basic Protein in the Cerebrospinal Fluid of Patients with Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1980
- "Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasmsBlood, 1978
- Intrathecal methotrexate overdose without neurotoxicity.Case report and literature reviewCancer, 1978
- Radioimmunoassay of Myelin Basic Protein in Spinal FluidNew England Journal of Medicine, 1976
- Neurotoxicity and Elevated Cerebrospinal-Fluid Methotrexate Concentration in Meningeal LeukemiaNew England Journal of Medicine, 1973
- Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlatesJournal of Clinical Investigation, 1969
- Absence of neurotoxicity following massive intrathecal administration of methotrexate.Case reportCancer, 1967